Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Lilia Winck-Flyvholm, Karen Damgaard Pedersen, Simone Hildorf & Jorgen Thorup. (2021) Evaluation of boys with daytime incontinence by combined cystourethroscopy, voiding cystourethrography and urodynamics. Scandinavian Journal of Urology 55:3, pages 249-256.
Read now
Read now
Tiernan Middleton & Pamela Ellsworth. (2019) Pharmacologic therapies for the management of non-neurogenic urinary incontinence in children. Expert Opinion on Pharmacotherapy 20:18, pages 2335-2352.
Read now
Read now
Amr S. El-Dakhakhny, Tarek M. El-Karamany, Mohamed El-Atrebi & Tarek Gharib. (2019) Efficacy and safety of intradetrusor onabotulinumtoxinA injection for managing paediatric non-neurogenic overactive bladder: A prospective case-series study. Arab Journal of Urology 17:2, pages 143-149.
Read now
Read now
Howard B. Goldman, Jean-Jacques Wyndaele, Steven A. Kaplan, Joseph T. Wang & Fady Ntanios. (2014) Defining response and non-response to treatment in patients with overactive bladder: a systematic review. Current Medical Research and Opinion 30:3, pages 509-526.
Read now
Read now
Articles from other publishers (21)
José A. Câncio Martins Bissaia Barreto, Maria I. Táboas Simões, Gonçalo Gomes Engenheiro, Joana I. Ferreira Matos & Joana A. Rodrigues Leal. (2023) The role of botulinum toxin in the management of nonneurogenic overactive bladder in children: Highlights for clinical practice. A systematic review. Current Urology.
Crossref
Crossref
Jisung Shim & Mi Mi Oh. (2023) Updates of Overactive Bladder in Pediatrics. International Neurourology Journal 27:1, pages 3-14.
Crossref
Crossref
Albert Kaufmann & Stephanie Knüpfer. 2023. Die Urologie. Die Urologie
1935
1941
.
Hann-Chorng Kuo. (2022) Clinical Application of Botulinum Neurotoxin in Lower-Urinary-Tract Diseases and Dysfunctions: Where Are We Now and What More Can We Do?. Toxins 14:7, pages 498.
Crossref
Crossref
Albert Kaufmann & Stephanie Knüpfer. 2020. Die Urologie. Die Urologie
1
7
.
Michaela Brown, Paula R. Williamson, Laura Sutton, Charlotte Melling, Malcolm Lewis, Nicholas J.A. Webb & Anju Goyal. (2021) Onabotulinum toxin-A versus extended release tolterodine in the management of idiopathic overactive bladder in children: A pilot randomised controlled trial (OVERT trial). Journal of Pediatric Urology 17:1, pages 77.e1-77.e12.
Crossref
Crossref
Yuan-Hong Jiang, Sheng-Fu Chen & Hann-Chorng Kuo. (2020) Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction. International Neurourology Journal 24:4, pages 301-312.
Crossref
Crossref
Charlotte Victoria Melling & Anju Goyal. (2020) Current pharmacological management of idiopathic overactive bladder in children in the UK: a national survey of practice. Journal of Pediatric Urology 16:1, pages 37.e1-37.e8.
Crossref
Crossref
Ghazi M. Al Edwan, Hammam H. Mansi, Omar Nabeeh M. Atta, Mohammad M. Shaath, Rawand Al Adwan, Waleed Mahafza, Kameel M. Afram, Omar Ababneh, Deema Al Adwan & Muheilan M. Muheilan. (2019) Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: A preliminary report. Journal of Pediatric Surgery 54:3, pages 595-599.
Crossref
Crossref
J. Ingham, R. Angotti, M. Lewis & A. Goyal. (2019) Onabotulinum toxin A in children with refractory idiopathic overactive bladder: medium-term outcomes. Journal of Pediatric Urology 15:1, pages 32.e1-32.e5.
Crossref
Crossref
Adam Althaus & Anurag K. Das. 2019. Smith's Textbook of Endourology. Smith's Textbook of Endourology
1775
1783
.
Israel Franco. (2016) Overactive bladder in children. Nature Reviews Urology 13:9, pages 520-532.
Crossref
Crossref
Lane S. Palmer. (2016) Evaluation and Targeted Therapy of Voiding Dysfunction in Children. Urology 92, pages 87-94.
Crossref
Crossref
Christina B. Ching. (2016) Current Treatment Options for Nonneurogenic Overactive Bladder in Children. Current Bladder Dysfunction Reports 11:1, pages 29-37.
Crossref
Crossref
Albert Kaufmann. 2016. Die Urologie. Die Urologie
1029
1035
.
Yuan-Hong Jiang, Chun-Hou Liao & Hann-Chorng Kuo. (2015) Current and potential urological applications of botulinum toxin A. Nature Reviews Urology 12:9, pages 519-533.
Crossref
Crossref
Fábio Quintiliano, Maria Luiza Veiga, Marília Moraes, Carolina Cunha, Liliana Fajardo de Oliveira, Patrícia Lordelo, José Murillo Bastos Netto & Ubirajara Barroso Júnior. (2015) Transcutaneous Parasacral Electrical Stimulation vs Oxybutynin for the Treatment of Overactive Bladder in Children: A Randomized Clinical Trial. Journal of Urology 193:5S, pages 1749-1753.
Crossref
Crossref
Priscilla Léon, Catherine Jolly, Aurélien Binet, Caroline Fiquet, Christine Vilette, Francis Lefebvre, Marie-Agnès Bouché-Pillon-Persyn & Marie-Laurence Poli-Mérol. (2014) Botulinum toxin injections in the management of non-neurogenic overactive bladders in children. Journal of Pediatric Surgery 49:9, pages 1424-1428.
Crossref
Crossref
M. Kask, R. Rintala & S. Taskinen. (2014) Effect of onabotulinumtoxinA treatment on symptoms and urodynamic findings in pediatric neurogenic bladder. Journal of Pediatric Urology 10:2, pages 280-283.
Crossref
Crossref
Albert Kaufmann. 2014. Die Urologie. Die Urologie
1
10
.
Nicol C. Bush. 2013. Pediatric Urology. Pediatric Urology
35
51
.